Stay updated on ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page shows a redesigned layout and updated visuals for the Study Details page, but no study data or eligibility content appears to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:07:02.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Added a government-status notice and a v3.2.0 revision; removed the v3.1.0 revision. The page now informs users about potential delays and where to check current operating status, and indicates the new version.
    Difference
    6%
    Check dated 2025-10-06T05:25:43.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:05:07.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.3%
    Check dated 2025-09-14T19:02:35.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.
    Difference
    0.3%
    Check dated 2025-09-07T14:58:55.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as updated drug information for Acalabrutinib and Pembrolizumab. However, several key details, such as specific location terms and previous drug information, have been removed.
    Difference
    4%
    Check dated 2025-08-31T11:48:26.000Z thumbnail image

Stay in the know with updates to ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page.